Emil H. Schemitsch, MD, FIOTA

University of Western Ontario
University of Western Ontario

Presentation(s):

• BSFF/ISFR Symposium II: Geriatric Fractures

  Wednesday, October 23, 2024
  9:40 AM EDT

  Financial Disclosures: Acumed, LLC: Paid consultant|Amgen Co: Paid consultant|Biocomposites: Research support|Canadian Orthopaedic Association: Board or committee member|DePuy, A Johnson & Johnson Company: Other financial or material support|Heron Therapeutics: Paid consultant|ITS: IP royalties; Paid consultant|Journal of Orthopaedic Trauma: Editorial or governing board|Orthopaedic Trauma Association: Board or committee member|Orthopaedic Trauma Association International: Editorial or governing board|Pentopharm: Paid consultant|Sanofi-Aventis: Paid consultant|Saunders/Mosby-Elsevier: Publishing royalties, financial or material support|Smith & Nephew: Other financial or material support; Paid consultant; Research support|Springer: Publishing royalties, financial or material support|Stryker: IP royalties; Other financial or material support; Paid consultant|Swemac: Paid consultant|Synthes: Paid consultant|Zimmer: Other financial or material support|

• Predictors of Adverse Events Following Intramedullary and Extramedullary Fixation of Trochanteric Hip Fractures

  Wednesday, October 23, 2024
  10:43 AM - 10:49 AM EDT

  Financial Disclosure N/A

• Surgical Approach Impacts Patient-Reported Symptoms Following Arthroplasty for Femoral Neck Fractures

  Wednesday, October 23, 2024
  11:00 AM - 11:06 AM EDT

  Financial Disclosure N/A

• Choice of Stem May Impact Reoperation Following Arthroplasty for Femoral Neck Fracture

  Wednesday, October 23, 2024
  11:12 AM - 11:18 AM EDT

  Financial Disclosure N/A

• BSFF Podium Session II: Geriatric Fracture Fixation

  Wednesday, October 23, 2024
  10:50 AM EDT

  Financial Disclosures: Acumed, LLC: Paid consultant|Amgen Co: Paid consultant|Biocomposites: Research support|Canadian Orthopaedic Association: Board or committee member|DePuy, A Johnson & Johnson Company: Other financial or material support|Heron Therapeutics: Paid consultant|ITS: IP royalties; Paid consultant|Journal of Orthopaedic Trauma: Editorial or governing board|Orthopaedic Trauma Association: Board or committee member|Orthopaedic Trauma Association International: Editorial or governing board|Pentopharm: Paid consultant|Sanofi-Aventis: Paid consultant|Saunders/Mosby-Elsevier: Publishing royalties, financial or material support|Smith & Nephew: Other financial or material support; Paid consultant; Research support|Springer: Publishing royalties, financial or material support|Stryker: IP royalties; Other financial or material support; Paid consultant|Swemac: Paid consultant|Synthes: Paid consultant|Zimmer: Other financial or material support|

• Presidential Welcome and Donor Acknowledgements

  Thursday, October 24, 2024
  8:00 AM - 8:15 AM EDT

  Financial Disclosure N/A

• A Randomized Controlled Trial of Locked Plating Versus Retrograde Nailing for Periprosthetic Distal Femur Fractures

  Thursday, October 24, 2024
  8:25 AM - 8:31 AM EDT

  Financial Disclosure N/A

• Long Bone Shaft, Pelvis, and Acetabular Fracture Fixation in Polytrauma: Priorities in the Context of Traumatic Injuries of the Head, Chest, Abdomen, Spine, Spinal Cord, and Vasculature

  Thursday, October 24, 2024
  9:31 AM - 9:37 AM EDT

  Financial Disclosure N/A

• An Image Processing Method for Assessing Bone Healing: A Pilot Study

  Thursday, October 24, 2024
  10:07 AM - 10:13 AM EDT

  Financial Disclosure N/A

• Does Surgical Fixation of Flail Chest Injuries Improve Pulmonary Function? Results From a Multicenter Randomized Controlled Trial

  Thursday, October 24, 2024
  4:12 PM - 4:18 PM EDT

  Financial Disclosure N/A

• President's Message: The Things That Really Matter!

  Thursday, October 24, 2024
  4:35 PM - 5:00 PM EDT

  Financial Disclosures: Acumed, LLC: Paid consultant|Amgen Co: Paid consultant|Biocomposites: Research support|Canadian Orthopaedic Association: Board or committee member|DePuy, A Johnson & Johnson Company: Other financial or material support|Heron Therapeutics: Paid consultant|ITS: IP royalties; Paid consultant|Journal of Orthopaedic Trauma: Editorial or governing board|Orthopaedic Trauma Association: Board or committee member|Orthopaedic Trauma Association International: Editorial or governing board|Pentopharm: Paid consultant|Sanofi-Aventis: Paid consultant|Saunders/Mosby-Elsevier: Publishing royalties, financial or material support|Smith & Nephew: Other financial or material support; Paid consultant; Research support|Springer: Publishing royalties, financial or material support|Stryker: IP royalties; Other financial or material support; Paid consultant|Swemac: Paid consultant|Synthes: Paid consultant|Zimmer: Other financial or material support|

• John Border, MD Memorial Lecture - An Up Close and Personal Conversation with OTA Past Presidents

  Friday, October 25, 2024
  9:00 AM - 10:00 AM EDT

  Financial Disclosures: Acumed, LLC: Paid consultant|Amgen Co: Paid consultant|Biocomposites: Research support|Canadian Orthopaedic Association: Board or committee member|DePuy, A Johnson & Johnson Company: Other financial or material support|Heron Therapeutics: Paid consultant|ITS: IP royalties; Paid consultant|Journal of Orthopaedic Trauma: Editorial or governing board|Orthopaedic Trauma Association: Board or committee member|Orthopaedic Trauma Association International: Editorial or governing board|Pentopharm: Paid consultant|Sanofi-Aventis: Paid consultant|Saunders/Mosby-Elsevier: Publishing royalties, financial or material support|Smith & Nephew: Other financial or material support; Paid consultant; Research support|Springer: Publishing royalties, financial or material support|Stryker: IP royalties; Other financial or material support; Paid consultant|Swemac: Paid consultant|Synthes: Paid consultant|Zimmer: Other financial or material support|

• Annual Meeting Symposium IV: Evidenced Based Management of the Orthopaedic Poly-Trauma Patient: A Canadian Orthopaedic Trauma Society (COTS) Perspective

  Saturday, October 26, 2024
  8:00 AM - 9:00 AM EDT

  Financial Disclosures: Acumed, LLC: Paid consultant|Amgen Co: Paid consultant|Biocomposites: Research support|Canadian Orthopaedic Association: Board or committee member|DePuy, A Johnson & Johnson Company: Other financial or material support|Heron Therapeutics: Paid consultant|ITS: IP royalties; Paid consultant|Journal of Orthopaedic Trauma: Editorial or governing board|Orthopaedic Trauma Association: Board or committee member|Orthopaedic Trauma Association International: Editorial or governing board|Pentopharm: Paid consultant|Sanofi-Aventis: Paid consultant|Saunders/Mosby-Elsevier: Publishing royalties, financial or material support|Smith & Nephew: Other financial or material support; Paid consultant; Research support|Springer: Publishing royalties, financial or material support|Stryker: IP royalties; Other financial or material support; Paid consultant|Swemac: Paid consultant|Synthes: Paid consultant|Zimmer: Other financial or material support|

• Guest Nation Recognition and Presentation

  Saturday, October 26, 2024
  9:21 AM - 9:30 AM EDT

  Financial Disclosures: Acumed, LLC: Paid consultant|Amgen Co: Paid consultant|Biocomposites: Research support|Canadian Orthopaedic Association: Board or committee member|DePuy, A Johnson & Johnson Company: Other financial or material support|Heron Therapeutics: Paid consultant|ITS: IP royalties; Paid consultant|Journal of Orthopaedic Trauma: Editorial or governing board|Orthopaedic Trauma Association: Board or committee member|Orthopaedic Trauma Association International: Editorial or governing board|Pentopharm: Paid consultant|Sanofi-Aventis: Paid consultant|Saunders/Mosby-Elsevier: Publishing royalties, financial or material support|Smith & Nephew: Other financial or material support; Paid consultant; Research support|Springer: Publishing royalties, financial or material support|Stryker: IP royalties; Other financial or material support; Paid consultant|Swemac: Paid consultant|Synthes: Paid consultant|Zimmer: Other financial or material support|